Top Page
Asahi Intecc Co
(7747)
Asahi Intecc Co (7747) vs. iShares MSCI Japan ETF (EWJ)
Asahi Intecc Co Business Overview & Revenue Model
Asahi Intecc Co Financial Statement Overview
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 120.03B | 107.55B | 90.10B | 77.75B | 61.51B |
| Gross Profit | 78.23B | 69.05B | 58.83B | 51.08B | 41.47B |
| EBITDA | 29.02B | 31.73B | 26.73B | 23.34B | 18.20B |
| Net Income | 12.74B | 15.81B | 13.11B | 10.86B | 9.98B |
Balance Sheet | |||||
| Total Assets | 193.19B | 191.61B | 172.64B | 155.13B | 115.43B |
| Cash, Cash Equivalents and Short-Term Investments | 54.20B | 38.66B | 36.88B | 32.32B | 21.36B |
| Total Debt | 11.10B | 6.70B | 14.25B | 12.18B | 8.04B |
| Total Liabilities | 41.83B | 39.65B | 38.35B | 34.00B | 22.49B |
| Stockholders Equity | 150.56B | 151.22B | 132.31B | 119.46B | 92.91B |
Cash Flow | |||||
| Free Cash Flow | 32.45B | 24.83B | 6.85B | 9.32B | -986.00M |
| Operating Cash Flow | 40.54B | 34.71B | 19.14B | 17.30B | 8.92B |
| Investing Cash Flow | -13.43B | -21.22B | -15.13B | -18.70B | -16.33B |
| Financing Cash Flow | -8.11B | -13.88B | -2.34B | 11.37B | 10.11B |
Asahi Intecc Co Technical Analysis
Asahi Intecc Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥165.12B | 33.41 | ― | 2.73% | 5.10% | -26.13% | |
69 Neutral | ¥3.12T | 24.33 | 9.31% | 1.22% | 7.68% | 10.08% | |
68 Neutral | ¥893.08B | 50.74 | 10.09% | 0.82% | 13.53% | -7.39% | |
63 Neutral | ¥229.78B | -95.13 | 5.66% | 2.66% | 5.43% | -20.67% | |
62 Neutral | ¥259.41B | 17.06 | 4.38% | 2.03% | 6.04% | 733.13% | |
60 Neutral | ¥1.68T | 20.24 | 13.13% | 1.01% | 0.42% | 34.76% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Asahi Intecc Co Corporate Events
Asahi Intecc Co. has announced a revision to its dividend forecast for the fiscal year ending June 30, 2026, coinciding with the 50th anniversary of its establishment on July 8, 2026. The company, which specializes in advanced medical device components and technologies, aims to commemorate this milestone and demonstrate appreciation to shareholders through enhanced returns.
The board has approved a year-end dividend forecast of ¥46.10 per share, up from the previous forecast of ¥30.91 and significantly higher than the prior year’s ¥24.23. This includes an ordinary dividend of ¥40.31 and a commemorative dividend of ¥5.79 per share, based on a targeted consolidated payout ratio of 35%, reflecting steady business performance and an upward revision to earnings projections.
Management indicated that the enhanced dividend plan balances shareholder returns with considerations for future business development and the company’s financial position. The final year-end dividend will be formally decided by the board in August 2026 and at the shareholders’ meeting in September 2026, meaning investors will be watching operational trends and earnings delivery closely as the anniversary year progresses.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2759.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc revised its full-year consolidated earnings forecast for the fiscal year ending June 30, 2026, projecting a significant increase in operating profit driven by strong sales in both its Medical and Device businesses and favorable foreign exchange rates. The company also expects a marked improvement in its gross profit margin, from 66.3% to 69.9%, helped by productivity gains and restrained selling, general and administrative expenses despite higher performance-based bonuses.
Non-operating expenses are projected to remain largely unchanged, while net profit attributable to owners will benefit from gains on sales of investment securities, underscoring broad-based profit growth. In line with the improved outlook, Asahi Intecc plans to revise its ordinary dividend upward and add a commemorative dividend to mark its 50th anniversary, signaling management’s confidence and offering additional returns to shareholders.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2759.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc has sharply revised upward its full-year consolidated forecast for the fiscal year ending June 30, 2026, citing stronger-than-expected performance in both its Medical and Device divisions and favorable foreign exchange rates. The company now projects net sales of ¥141.1 billion and profit attributable to owners of parent of ¥30.6 billion, representing notable increases of 7.8% and 28.3% respectively over its previous guidance and a substantial improvement from the prior fiscal year.
Management attributes the higher outlook to robust overseas demand in the Medical Division, increased transactions in medical and industrial components in the Device Division, and improved productivity lifting gross profit beyond initial expectations. While selling, general and administrative expenses are set to rise due to performance-linked bonuses and alignment with original spending plans, higher gross profit and a gain on sales of investment securities are expected to drive operating and ordinary profit significantly above earlier forecasts, signaling stronger earnings power and enhanced returns for shareholders and employees.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2759.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc Co. reported consolidated net sales of 71,266 million yen for the first half of the fiscal year ending June 2026, a year-on-year increase of 15.9 percent, driven by solid performance in both its Medical and Device divisions. The Medical Division saw robust growth in cardiovascular products, notably PCI guidewires and penetration catheters across all regions, and in non-cardiovascular areas such as peripheral devices worldwide and abdominal products outside China.
The Device Division posted higher sales in both medical and industrial components, supported by the consolidation of Nitta Mold as a subsidiary and increased business in U.S. cardiovascular inspection catheter components. Industrial components also benefited from stronger overseas leisure-related demand, while a weaker yen added 1,065 million yen to sales, underscoring the company’s exposure to currency movements and its expanding international footprint.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2759.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc reported strong results for the six months ended Dec. 31, 2025, with net sales rising 15.9% year on year to ¥71.27 billion and profit attributable to owners of parent up 40.4% to ¥17.21 billion. Operating profit jumped 40.1% to ¥24.37 billion, lifting the equity-to-asset ratio to 80.6% and pushing basic earnings per share to ¥64.56.
The company revised its full-year forecast higher, now projecting net sales of ¥141.14 billion and a 139.9% surge in profit attributable to owners of parent to ¥30.56 billion. It also raised its dividend outlook, planning a total annual dividend of ¥46.10 per share for the year to June 30, 2026, including a commemorative payout, signaling confidence in earnings strength and balance sheet resilience.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2759.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc has published its “Integrated Report 2025” on its website, consolidating financial and non-financial information to explain how the group intends to enhance corporate value over the long term. Centered on the company’s newly launched medium-term management plan, the report details the group’s medium- to long-term vision, specific strategies and measures for sustainable growth, and a roadmap that builds on its technological strengths and operational capabilities. It also incorporates perspectives from external analysts on the objectives and priority areas of the new plan, as well as the company’s approach to growth and financial strategy, offering stakeholders a multi-dimensional view of the plan’s background and execution resolve. In addition, the report highlights the effectiveness of the Board of Directors through dialogues with outside directors, interviews with audit and supervisory members, and commentary from a former outside director, showcasing the company’s governance framework and oversight functions as it strives to be a trusted, continuously growing enterprise.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen3153.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.